VIVO BIO (India) Today

Equity ratings for VIVO BIO TECH are calculated daily based on our scoring framework. The performance scores are derived for the period starting the 8th of January 2021 and ending today, the 4th of December 2021. Click here to learn more.
VIVO BIO TECH cannot be verified against its exchange. It looks like VIVO BIO is not available for investing at the moment. Please verify the symbol is currently traded on Bombay Stock Exchange. If you still believe the symbol you are trying to look up is valid please let us know and we will check it as soon as possible.
Refresh

VIVO BIO Stock Highlights

Most reasonable investors view market volatility as an opportunity to invest at a favorable price or to sell short against a bearish trend. If you consider yourself one of those investors, make sure you clearly understand your entering position. VIVO BIO's investment highlights are automatically generated signals that are significant enough to either complement your investing judgment regarding VIVO BIO or challenge it. These highlights can help you better understand the position you are entering and avoid costly mistakes.
VIVO BIO TECH is not yet fully synchronised with the market data
VIVO BIO TECH has some characteristics of a very speculative penny stock
VIVO BIO TECH has high likelihood to experience some financial distress in the next 2 years
VIVO BIO TECH has accumulated 216.77 Million in debt which can lead to volatile earnings
Legal NameVIVO BIO TECH
Macroaxis Advice
Unlike general analyst consensus, Macroaxis buy hold or sell recommendation is provided in the context of your current investment horizon and risk tolerance. The advice algorithm takes into account all of VIVO BIO's available fundamental, technical, and predictive indicators. Your current horizon is 90 days - details
Not RatedUndervalued
VIVO BIO TECH (VIVOBIOT) is traded on Bombay Stock Exchange in India and employs 183 people. The company currently falls under 'Small-Cap' category with current market capitalization of 377.73 M. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate VIVO BIO's market, we take the total number of its shares issued and multiply it by VIVO BIO's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and these looking for more risk prefer small-cap and mid-cap equities. VIVO BIO TECH operates under Healthcare sector and is part of Biotechnology industry. The entity has 12.75 M outstanding shares. VIVO BIO TECH has accumulated about 5.63 M in cash with 111.1 M of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.44.
Check VIVO BIO Probability Of Bankruptcy

VIVOBIOT Stock Against Markets

Picking the right benchmark for VIVO BIO stock is fundamental to making educated investment choices. Many naive investors compare their positions with the S&P 500 or with the Nasdaq. But these benchmarks are not all-inclusive and generally should be used only for large-capitalization equities or stock offerings from large companies. When the price of a selected benchmark declines in a down market, there may be an uptick in VIVO BIO stock price where buyers come in believing the asset is cheap. The opposite is true when the market is bullish; so, accurately picking the benchmark for VIVO BIO is critical whether you are bullish or bearish towards VIVO BIO TECH at a given time.
VIVO BIO TECH cannot be verified against its exchange. It looks like VIVO BIO is not available for investing at the moment. Please verify the symbol is currently traded on Bombay Stock Exchange. If you still believe the symbol you are trying to look up is valid please let us know and we will check it as soon as possible.
Refresh

Try Other Stock Suggestions

View Currently Related Equities

One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with VIVO BIO stock to make a market-neutral strategy. Peer analysis of VIVO BIO could also be used in its relative valuation, which is a method of valuing VIVO BIO by comparing valuation metrics with similar companies.
Check out World Market Map. Note that the VIVO BIO TECH information on this page should be used as a complementary analysis to other VIVO BIO's statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try Probability Of Bankruptcy module to get analysis of equity chance of financial distress in the next 2 years.

Other Tools for VIVOBIOT Stock

When running VIVO BIO TECH price analysis, check to measure VIVO BIO's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy VIVO BIO is operating at the current time. Most of VIVO BIO's value examination focuses on studying past and present price action to predict the probability of VIVO BIO's future price movements. You can analyze the entity against its peers and financial market as a whole to determine factors that move VIVO BIO's price. Additionally, you may evaluate how the addition of VIVO BIO to your portfolios can decrease your overall portfolio volatility.
Equity Forecasting
Use basic forecasting models to generate price predictions and determine price momentum
Go
Portfolio Rebalancing
Analyze risk-adjusted returns against different time horizons to find asset-allocation targets
Go
Idea Optimizer
Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio
Go
Equity Analysis
Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities
Go
Fundamental Analysis
View fundamental data based on most recent published financial statements
Go